Bisphenol A-Induced Endocrine Dysfunction and its Associated Metabolic Disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and molecular pathways without systematic methodology.
PubMed 36173044 · doi:10.2174/1871530322666220928144043
What was done
This narrative review summarizes literature regarding the cellular and molecular mechanisms of bisphenol A (BPA) exposure and its associated endocrine dysfunctions and metabolic disorders, including obesity, fatty liver diseases, insulin resistance, and polycystic ovarian syndrome.
What was found
The abstract reports no numerical findings, effect estimates, or sample metrics. It qualitatively describes mechanisms whereby BPA acts as an agonist or antagonist via estrogen and G-protein coupled receptors, activates pathways influencing apoptosis and inflammation, stimulates adipogenesis and lipid accumulation, elevates oxidative mediators, reduces antioxidant enzymes, and causes mitochondrial dysfunction.
Why it matters
It provides an overview of putative molecular and cellular pathways through which environmental exposure to BPA can contribute to metabolic syndrome and related endocrine disorders.
Limits
The abstract describes a narrative review without systematic search protocols, quality appraisal, or study selection criteria. It provides no quantitative data, human clinical outcome measurements, or exposure threshold details, relying primarily on mechanistic reasoning.
Cited by
- supports BPA acts as an estrogen mimic in the body.